Literature DB >> 2139699

Absence of interleukin 2 production in a severe combined immunodeficiency disease syndrome with T cells.

J P DiSanto1, C A Keever, T N Small, G L Nicols, R J O'Reilly, N Flomenberg.   

Abstract

We have characterized a child with a severe combined immunodeficiency disease syndrome with increased numbers, but a normal distribution, of CD3+ T cells. This patient's immunological defect appears to be attributable to a selective deficiency in T cell production of IL-2, which may reflect a subtle abnormality in the IL-2 gene locus or a defect in a regulatory factor necessary for IL-2 transcription. The increased numbers of phenotypically normal T cells in this patient suggest that alternative pathways of T cell development exist in man or that IL-2 production intra- and extrathymically is controlled via distinct regulatory mechanisms.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2139699      PMCID: PMC2187905          DOI: 10.1084/jem.171.5.1697

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  19 in total

1.  Contingent genetic regulatory events in T lymphocyte activation.

Authors:  G R Crabtree
Journal:  Science       Date:  1989-01-20       Impact factor: 47.728

2.  An immunodeficiency characterized by defective signal transduction in T lymphocytes.

Authors:  T Chatila; R Wong; M Young; R Miller; C Terhorst; R S Geha
Journal:  N Engl J Med       Date:  1989-03-16       Impact factor: 91.245

3.  Familial defect in the surface expression of the T-cell receptor-CD3 complex.

Authors:  B Alarcon; J R Regueiro; A Arnaiz-Villena; C Terhorst
Journal:  N Engl J Med       Date:  1988-11-03       Impact factor: 91.245

Review 4.  Immunodeficiency diseases.

Authors:  R H Buckley
Journal:  JAMA       Date:  1987-11-27       Impact factor: 56.272

5.  Identification of a putative regulator of early T cell activation genes.

Authors:  J P Shaw; P J Utz; D B Durand; J J Toole; E A Emmel; G R Crabtree
Journal:  Science       Date:  1988-07-08       Impact factor: 47.728

6.  Molecular cloning of an inducible serine esterase gene from human cytotoxic lymphocytes.

Authors:  J A Trapani; J L Klein; P C White; B Dupont
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

Review 7.  Interleukin-2: inception, impact, and implications.

Authors:  K A Smith
Journal:  Science       Date:  1988-05-27       Impact factor: 47.728

8.  Molecular cloning and expression of cDNAs for the human interleukin-2 receptor.

Authors:  W J Leonard; J M Depper; G R Crabtree; S Rudikoff; J Pumphrey; R J Robb; M Krönke; P B Svetlik; N J Peffer; T A Waldmann
Journal:  Nature       Date:  1984 Oct 18-24       Impact factor: 49.962

9.  Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins.

Authors:  G G Wong; J S Witek; P A Temple; K M Wilkens; A C Leary; D P Luxenberg; S S Jones; E L Brown; R M Kay; E C Orr
Journal:  Science       Date:  1985-05-17       Impact factor: 47.728

10.  Age-related changes in human lymphocyte subsets: progressive reduction of the CD4 CD45R (suppressor inducer) population.

Authors:  P De Paoli; S Battistin; G F Santini
Journal:  Clin Immunol Immunopathol       Date:  1988-09
View more
  11 in total

Review 1.  Primary T-lymphocyte immunodeficiencies.

Authors:  A Fischer
Journal:  Clin Rev Allergy Immunol       Date:  2001-02       Impact factor: 8.667

2.  Primary combined immunodeficiency resulting from defective transcription of multiple T-cell lymphokine genes.

Authors:  T Chatila; E Castigli; R Pahwa; S Pahwa; N Chirmule; N Oyaizu; R A Good; R S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

3.  Expression of the type 1 human immunodeficiency virus Nef protein in T cells prevents antigen receptor-mediated induction of interleukin 2 mRNA.

Authors:  S Luria; I Chambers; P Berg
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

Review 4.  X-linked severe combined immunodeficiency disease and the gamma c receptor component: prospects for molecular diagnosis.

Authors:  N L Farner; S D Voss; P M Sondel
Journal:  Clin Diagn Lab Immunol       Date:  1995-09

Review 5.  Immunodeficiency due to mutations in ORAI1 and STIM1.

Authors:  Stefan Feske; Capucine Picard; Alain Fischer
Journal:  Clin Immunol       Date:  2010-03-01       Impact factor: 3.969

6.  Defective expression of early activation genes in cartilage-hair hypoplasia (CHH) with severe combined immunodeficiency (SCID).

Authors:  E Castigli; A M Irani; R S Geha; T Chatila
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

7.  Defective human interleukin 2 receptor gamma chain in an atypical X chromosome-linked severe combined immunodeficiency with peripheral T cells.

Authors:  J P DiSanto; F Rieux-Laucat; A Dautry-Varsat; A Fischer; G de Saint Basile
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

8.  Interleukin 12 deficiency associated with recurrent infections.

Authors:  S Haraguchi; N K Day; R P Nelson; P Emmanuel; J E Duplantier; C S Christodoulou; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

9.  Primary T lymphocyte immunodeficiency associated with a selective impairment of CD2, CD3, CD43 (but not CD28)-mediated signal transduction.

Authors:  C Rodríguez-Gallego; A Arnaiz-Villena; A Corell; J Manzanares; M Timón; A Pacheco; J R Regueiro
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

10.  Expression of immunoglobulin genes in common variable immunodeficiency.

Authors:  H Kaneko; N Kondo; F Motoyoshi; S Mori; Y Kobayashi; Y Inoue; T Orii
Journal:  J Clin Immunol       Date:  1991-09       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.